AP
XLRN

AtonRa Partners’s Acceleron Pharma XLRN Stock Holding History

AtonRa Partners’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,539
Closed -$1.64M – 117
2021
Q3 		$1.64M Buy
9,539
+741
+8% +$96.9K 0.55% 74
2021
Q2 		$1.1M Buy
+8,798
New +$1.11M 0.4% 86

AtonRa Partners's XLRN Position: Q4 2021 in Review

AtonRa Partners sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 9,539 shares — an estimated $1.64M sold.

AtonRa Partners first reported a position in XLRN in Q2 2021 and held it in 2 quarters. The position peaked at $1.64M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • AtonRa Partners reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • AtonRa Partners sold 9,539 Acceleron Pharma shares in Q4 2021, an estimated $1.64M.
  • AtonRa Partners first reported a position in Acceleron Pharma in Q2 2021 and held it in 2 quarters.
  • AtonRa Partners's Acceleron Pharma position peaked at $1.64M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on AtonRa Partners's 13F filing for Q4 2021, filed 14 Feb 2022.